Everolimus and Letrozole in Treating Patients With Recurrent Hormone Receptor Positive Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer
Conditions
- Ovarian Endometrioid Adenocarcinoma
- Ovarian Seromucinous Carcinoma
- Ovarian Serous Cystadenocarcinoma
- Ovarian Serous Surface Papillary Adenocarcinoma
- Recurrent Fallopian Tube Carcinoma
- Recurrent Ovarian Carcinoma
- Recurrent Ovarian Germ Cell Tumor
- Recurrent Primary Peritoneal Carcinoma
- Undifferentiated Ovarian Carcinoma
Interventions
- DRUG: Everolimus
- OTHER: Laboratory Biomarker Analysis
- DRUG: Letrozole
Sponsor
Mayo Clinic
Collaborators